Genetic imaging consortium for addiction medicine: From neuroimaging to genes

Scott Mackey¹, Kees-Jan Kan², Bader Chaarani², Nelly Alia-Klein³, Albert Batalla⁴, Samantha Brooks⁵, Janna Cousijn⁵, Alain Dagher⁶, Michiel de Ruiter⁷, Sylvane Desrivieres⁸, Sarah W Feldstein Ewing⁹, Rita Z Goldstein³, Anna E Goudriaan¹⁰, Mary M Heitzeg¹¹, Kent Hutchison¹², Chiang-Shan R Li¹³, Edythe D London¹⁴, Valentina Lorenzetti¹⁵, Maartje Luijten¹⁶, Rocio Martin-Santos¹⁷, Angelica M Morales¹⁸, Martin P Paulus¹⁹, Tomas Paus²⁰, Godfrey Pearlson¹³, Renée Schluter²¹, Reza Momenan²², Lianne Schmaal²³, Gunter Schumann⁸, Rajita Sinha¹³, Zsuzsika Sjoerds²⁴, Dan J Stein⁵, Elliot A Stein²⁵, Nadia Solowij²⁶, Susan Tapert²⁷, Anne Uhlmann⁵, Dick Veltman²³, Ruth van Holst²¹, Henrik Walter²⁸, Margaret J Wright²⁹, Murat Yucel¹⁵, Deborah Yurgelun-Todd³⁰, Derrek P Hibar³¹, Neda Jahanshad³¹, Paul M Thompson³¹, David C Glahn¹³, Hugh Garavan², Patricia Conrod³²

Affiliations

¹ Departments of Psychiatry and Psychology, University of Vermont, Burlington, VT, USA. Electronic address: msmackey@uvm.edu.
² Departments of Psychiatry and Psychology, University of Vermont, Burlington, VT, USA.
³ Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
⁴ Department of Psychiatry and Psychology, Hospital Clínic, IDIBAPS, CIBERSAM, University of Barcelona, Barcelona, Spain; Department of Psychiatry, Radboud University Medical Centre, Nijmegen, The Netherlands.
⁵ Department of Psychiatry and MRC Unit on Anxiety & Stress Disorders, University of Cape Town, Cape Town, South Africa.
⁶ Montreal Neurological Institute, McGill University, Montreal, QC, Canada.
⁷ Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
⁸ Institute of Psychiatry, King's College London, London, UK.
⁹ Department of Psychiatry, Oregon Health & Science University, Portland, OR, USA.
¹⁰ Department of Psychiatry and MRC Unit on Anxiety & Stress Disorders, University of Cape Town, Cape Town, South Africa; Department of Psychiatry, University of Amsterdam, Amsterdam, The Netherlands.
¹¹ Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA.
¹² Department of Psychology and Neuroscience, University of Colorado Boulder, Boulder, CO, USA.
¹³ Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
¹⁴ Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA; David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA.
¹⁵ School of Psychological Sciences, Monash Institute of Cognitive and Clinical Neurosciences and Monash Biomedical Imaging, Monash University, Melbourne, Australia.
¹⁶ Behavioural Science Institute, Radboud University, Nijmegen, The Netherlands.
¹⁷ Department of Psychiatry and Psychology, Hospital Clínic, IDIBAPS, CIBERSAM, University of Barcelona, Barcelona, Spain.
¹⁸ David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA.
¹⁹ VA San Diego Healthcare System and Department of Psychiatry, University of California San Diego, La Jolla, CA, USA; Laureate Institute for Brain Research, Tulsa, OK, USA.
²⁰ Rotman Research Institute, University of Toronto, Toronto, ON, Canada.
²¹ Department of Psychiatry, University of Amsterdam, Amsterdam, The Netherlands.
²² Section on Brain Electrophysiology and Imaging, Institute on Alcohol Abuse and Alcoholism, Bethesda, USA.
²³ Department of Psychiatry, VU University Medical Center, Amsterdam, The Netherlands.
²⁴ Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.
²⁵ Intramural Research Program-Neuroimaging Research Branch, National Institute on Drug Abuse, Baltimore, MD, USA.
²⁶ School of Psychology, University of Wollongong, Wollongong, NSW, Australia.
²⁷ Laureate Institute for Brain Research, Tulsa, OK, USA.
²⁸ Department of Psychiatry and Psychotherapy, Charité Universitatsmedizin, Berlin, Germany.
²⁹ QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
³⁰ Department of Psychiatry, University of Utah School of Medicine, Salt Lake City, UT, USA.
³¹ Department of Neurology, Imaging Genetics Center, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.
³² Department of Psychiatry, Université de Montreal, CHU Ste Justine Hospital, Montreal, QC, Canada.

PMID: 26822360
PMCID: PMC4820288
DOI: 10.1016/bs.pbr.2015.07.026

Review

Genetic imaging consortium for addiction medicine: From neuroimaging to genes

Scott Mackey et al. Prog Brain Res. 2016.

. 2016:224:203-23.

doi: 10.1016/bs.pbr.2015.07.026. Epub 2015 Nov 4.

Authors

Affiliations

¹ Departments of Psychiatry and Psychology, University of Vermont, Burlington, VT, USA. Electronic address: msmackey@uvm.edu.
² Departments of Psychiatry and Psychology, University of Vermont, Burlington, VT, USA.
³ Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
⁴ Department of Psychiatry and Psychology, Hospital Clínic, IDIBAPS, CIBERSAM, University of Barcelona, Barcelona, Spain; Department of Psychiatry, Radboud University Medical Centre, Nijmegen, The Netherlands.
⁵ Department of Psychiatry and MRC Unit on Anxiety & Stress Disorders, University of Cape Town, Cape Town, South Africa.
⁶ Montreal Neurological Institute, McGill University, Montreal, QC, Canada.
⁷ Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
⁸ Institute of Psychiatry, King's College London, London, UK.
⁹ Department of Psychiatry, Oregon Health & Science University, Portland, OR, USA.
¹⁰ Department of Psychiatry and MRC Unit on Anxiety & Stress Disorders, University of Cape Town, Cape Town, South Africa; Department of Psychiatry, University of Amsterdam, Amsterdam, The Netherlands.
¹¹ Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA.
¹² Department of Psychology and Neuroscience, University of Colorado Boulder, Boulder, CO, USA.
¹³ Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
¹⁴ Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA; David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA.
¹⁵ School of Psychological Sciences, Monash Institute of Cognitive and Clinical Neurosciences and Monash Biomedical Imaging, Monash University, Melbourne, Australia.
¹⁶ Behavioural Science Institute, Radboud University, Nijmegen, The Netherlands.
¹⁷ Department of Psychiatry and Psychology, Hospital Clínic, IDIBAPS, CIBERSAM, University of Barcelona, Barcelona, Spain.
¹⁸ David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA.
¹⁹ VA San Diego Healthcare System and Department of Psychiatry, University of California San Diego, La Jolla, CA, USA; Laureate Institute for Brain Research, Tulsa, OK, USA.
²⁰ Rotman Research Institute, University of Toronto, Toronto, ON, Canada.
²¹ Department of Psychiatry, University of Amsterdam, Amsterdam, The Netherlands.
²² Section on Brain Electrophysiology and Imaging, Institute on Alcohol Abuse and Alcoholism, Bethesda, USA.
²³ Department of Psychiatry, VU University Medical Center, Amsterdam, The Netherlands.
²⁴ Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.
²⁵ Intramural Research Program-Neuroimaging Research Branch, National Institute on Drug Abuse, Baltimore, MD, USA.
²⁶ School of Psychology, University of Wollongong, Wollongong, NSW, Australia.
²⁷ Laureate Institute for Brain Research, Tulsa, OK, USA.
²⁸ Department of Psychiatry and Psychotherapy, Charité Universitatsmedizin, Berlin, Germany.
²⁹ QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
³⁰ Department of Psychiatry, University of Utah School of Medicine, Salt Lake City, UT, USA.
³¹ Department of Neurology, Imaging Genetics Center, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.
³² Department of Psychiatry, Université de Montreal, CHU Ste Justine Hospital, Montreal, QC, Canada.

PMID: 26822360
PMCID: PMC4820288
DOI: 10.1016/bs.pbr.2015.07.026

Abstract

Since the sample size of a typical neuroimaging study lacks sufficient statistical power to explore unknown genomic associations with brain phenotypes, several international genetic imaging consortia have been organized in recent years to pool data across sites. The challenges and achievements of these consortia are considered here with the goal of leveraging these resources to study addiction. The authors of this review have joined together to form an Addiction working group within the framework of the ENIGMA project, a meta-analytic approach to multisite genetic imaging data. Collectively, the Addiction working group possesses neuroimaging and genomic data obtained from over 10,000 subjects. The deadline for contributing data to the first round of analyses occurred at the beginning of May 2015. The studies performed on this data should significantly impact our understanding of the genetic and neurobiological basis of addiction.

Keywords: Addiction; ENIGMA; Genetic imaging; Neuroimaging.

PubMed Disclaimer

Figures

**Figure 1**
Illustration of a structural MRI brain scan processed with FreeSurfer. Left, example of automated parcellation of the cortex. Right, local cortical thickness projected onto inflated surface of the brain.

**Figure 2**
World map of the current membership of the ENIGMA Addiction working group.

See this image and copyright information in PMC

References

1. Agrawal A, Lynskey MT, Hinrichs A, Grucza R, Saccone SF, Krueger R, Neuman R, Howells W, Fisher S, Fox L, Cloninger R, Dick DM, Doheny KF, Edenberg HJ, Goate AM, Hesselbrock V, Johnson E, Kramer J, Kuperman S, Nurnberger JI, Jr, Pugh E, Schuckit M, Tischfield J, GENEVA Consortium. Rice JP, Bucholz KK, Bierut LJ. A genome-wide association study of DSM-IV cannabis dependence. Addict Biol. 2011;16:514–518. - PMC - PubMed
1. Agrawal A, Freedman ND, Cheng YC, Lin P, Shaffer JR, Sun Q, Taylor K, Yaspan B, Cole JW, Cornelis MC, DeSensi RS, Fitzpatrick A, Heiss G, Kang JH, O'Connell J, Bennett S, Bookman E, Bucholz KK, Caporaso N, Crout R, Dick DM, Edenberg HJ, Goate A, Hesselbrock V, Kittner S, Kramer J, Nurnberger JI, Jr, Qi L, Rice JP, Schuckit M, van Dam RM, Boerwinkle E, Hu F, Levy S, Marazita M, Mitchell BD, Pasquale LR, Bierut LJ GENEVA Consortium. Measuring alcohol consumption for genomic meta-analyses of alcohol intake: opportunities and challenges. Am J Clin Nutr. 2012;95:539–547. - PMC - PubMed
1. Alia-Klein N, Parvaz MA, Woicik PA, Konova AB, Maloney T, Shumay E, Wang R, Telang F, Biegon A, Wang GJ, Fowler JS, Tomasi D, Volkow ND, Goldstein RZ. Gene x disease interaction on orbitofrontal gray matter in cocaine addiction. Arch Gen Psychiatry. 2011;68:283–294. - PMC - PubMed
1. Ashbrook DG, Williams RW, Lu L, Stein JL, Hibar DP, Nichols TE, Medland SE, Thompson PM, Hager R. Joint genetic analysis of hippocampal size in mouse and human identifies a novel gene linked to neurodegenerative disease. BMC Genomics. 2014;15:850. - PMC - PubMed
1. Barros-Loscertales A, Garavan H, Bustamante JC, Ventura-Campos N, Llopis JJ, Belloch V, Parcet MA, Avila C. Reduced striatal volume in cocaine-dependent patients. Neuroimage. 2011;56:1021–1026. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Genetic imaging consortium for addiction medicine: From neuroimaging to genes

Affiliations

Genetic imaging consortium for addiction medicine: From neuroimaging to genes

Authors

Affiliations

Abstract

Figures

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Medical